RESUMO
A significantly strengthened Revised National Tuberculosis Control Programme (RNTCP) is currently operational in India. In this case-based commentary, we describe the plight of a patient who developed extensive drug-resistant tuberculosis (XDR-TB) despite having received treatment under the RNTCP for a long period. Our aim is to analyse the programmatic management of tuberculosis in India by highlighting and discussing various issues related to the treatment received by the patient. Further, the article explores whether there is a need to incorporate an ethical element into the RNTCP as it stands today.
Assuntos
Adulto , Antituberculosos/uso terapêutico , Diagnóstico Tardio/efeitos adversos , Atenção à Saúde/normas , Gerenciamento Clínico , Resistência a Medicamentos , Tuberculose Extensivamente Resistente a Medicamentos/diagnóstico , Tuberculose Extensivamente Resistente a Medicamentos/tratamento farmacológico , Tuberculose Extensivamente Resistente a Medicamentos/etiologia , Feminino , Necessidades e Demandas de Serviços de Saúde , Humanos , Índia , Erros Médicos , Prática de Saúde Pública/normas , Resultado do Tratamento , Tuberculose/tratamento farmacológico , Adulto JovemRESUMO
Primary pleuro-pulmonary synovial sarcoma (PPSS) is a rare tumour and poses a diagnostic challenge particularly when unusual histological features are present. We report a case of a 30-year-old immunocompromised human immunodeficiency virus (HIV) sero-positive male who was referred to us with complaints of cough, breathlessness and left-sided chest pain for the past two months. The PPSS can be confirmed on tru-cut biopsy.